March 15, 2012 (Press-News.org) Individuals suffering from Mesothelioma know all too well the aggressive nature of the disease. Fortunately, a new clinical trial shows positive results for some patients taking a particular type of chemotherapy combination.
What is Mesothelioma?
Mesothelioma is a rare type of cancer that afflicts the meothelium or thin membrane that covers a person's lungs, heart and other vital organs. The cancer is most commonly caused by the inhalation of microscopic asbestos fibers.
Asbestos fibers were first used by U.S. manufacturers and builders in the late 19th century as an insulator for electrical components and insulation in buildings because of their sound absorption qualities, strength, and resistance to fire and heat. In the midst of World War II, other industries, including steel mills, power and paper plants, shipbuilders and mariners began using asbestos. However, at the turn of the century, the public began to learn just how dangerous the product really was.
In the early 1900s, a significant percentage of people located in various mining towns across the country known to use asbestos were succumbing to lung problems and even died. Authorities tied the illnesses to asbestos and in the late 1970s, the U.S. Consumer Product Safety Commission--the federal agency in charge of protecting the public from injury or death resulting from consumer products--banned the manufacture and use of asbestos in certain consumer products. In 1989, all new uses of asbestos in all products were officially halted in the U.S.
Mesothelioma Treatment
Mesothelioma is one of the most serious and aggressive forms of cancer and has proved resistant to most kinds of treatment; possibly because symptoms of the disease do not appear until years after a person's exposure to asbestos which provides plenty of time for the cancer to grow and metastasize to other parts of the human body.
Today, chemotherapy is the traditional form used to fight the disease, but even this type of treatment is shown to result in only moderate impacts for patients. However, a group of research scientists in the Netherlands may have found the right chemo combination.
The Study
Between 1995 and 2006, three Dutch scientists analyzed roughly 4700 mesothelioma patients diagnosed with the condition and found that median survival rates for patients receiving the cisplatin-antifolate chemotherapy combination jumped from approximately 10 months to over 13 months.
Cisplatin, marketed as Platinol, is known to trigger apoptosis or death of the cancer cells. Cisplatin is then combined with antifolate (Alimta), a drug that blocks the activity of folic acid inside cells that interrupt cellular metabolism.
The study's authors, however, noted that outside factors could also play a part in the increase in survival time. "Due to the observational nature of this study alternative explanations cannot be excluded," one author noted. Further, the survival rates for peritoneal mesothelioma patients still remained poor.
Asbestos Exposure Today
Today, despite the prohibition on the manufacture and use of new products containing asbestos within the United States, many people are still at risk of being exposed to the dangerous product.
Since asbestos was utilized up until the late 1970s, many building or electrical materials in homes and commercial properties built before then still contain asbestos. Many workers or construction technicians remodeling, repairing, demolishing or renovating these properties today often disturb the asbestos within the materials. When disturbed, the fibers become airborne and ultimately inhaled by those within the vicinity of the construction project.
Luckily, countries, including the U.S., have promulgated rules to help minimize individuals' exposure to asbestos today. The Occupational Safety and Health Administration--the federal agency known as OSHA responsible for enforcing health and safety regulations--has implemented protocols that must be followed by anyone dealing with the repair, renovation, demolition, or maintenance of any structure that contains asbestos. In addition, the agency has employed asbestos spill and clean-up procedures as well as rules regarding the transportation, storage, and disposal of products containing asbestos.
The Fight Continues
It remains to be seen just how extensive and how long the damage associated with asbestos will have on individuals who have been or who potentially will be exposed to this hazardous product. It's estimated that over 2,000 individuals are diagnosed with mesothelioma every year. However, one thing is certain--the fight to mitigate the effects of this horrible disease, as demonstrated by continuous efforts from both the U.S. and countries abroad, will continue.
An Attorney Can Help
If you or a loved one has developed the symptoms of mesothelioma or asbestosis, contact an attorney experienced in asbestos litigation immediately. An experienced attorney can advise you of your rights and hold the responsible parties accountable.
Article provided by Law Offices of Wallace & Graham
Visit us at http://www.usmesotheliomalaw.com/
Study Shows Chemotherapy Combination Effective for Mesothelioma Patients
A particular combination of chemotherapy drugs is proving effective at treating Mesothelioma.
2012-03-15
ELSE PRESS RELEASES FROM THIS DATE:
Mystery human fossils put spotlight on China
2012-03-15
Fossils from two caves in south-west China have revealed a previously unknown Stone Age people and give a rare glimpse of a recent stage of human evolution with startling implications for the early peopling of Asia.
The fossils are of a people with a highly unusual mix of archaic and modern anatomical features and are the youngest of their kind ever found in mainland East Asia.
Dated to just 14,500 to 11,500 years old, these people would have shared the landscape with modern-looking people at a time when China's earliest farming cultures were beginning, says an international ...
Reducing drug overdose for ex-prisoners -- the view from outside the prison gates
2012-03-15
Prison inmates frequently have a strong history of drug use and misuse, especially during the time prior to incarceration, and drugs often are the driving force behind the offense itself. New research, published in BioMed Central's newly launched open access journal Addiction Science & Clinical Practice, shows that ex-offenders struggle to remain drug free after release from prison and identifies factors that can help them succeed. Interviews with former inmates show that they themselves recognize that returning to former living environments (former friends and an easy ...
Social networking shortcut to finding medical experts
2012-03-15
It can be difficult for someone outside of a specialist field to identify subject experts and the ever increasing amount of available data can be bewildering. New research, published in BioMed Central's open access journal, Journal of Biomedical Semantics, describes a method of social network analysis, similar to finding friends on Facebook, able to sift through scientific literature and news articles to identify opinion leaders and media experts.
Pharmaceutical companies and public health programs rely on opinion leaders to clarify and condense research into a format ...
'Personalized immune' mouse offers new tool for studying autoimmune diseases
2012-03-15
New York, NY (March 14, 2012) — Columbia University Medical Center (CUMC) scientists have developed a way to recreate an individual's immune system in a mouse. The "personalized immune mouse" offers researchers an unprecedented tool for individualized analysis of abnormalities that contribute to type 1 diabetes and other autoimmune diseases, starting at the onset of disease. The findings were published today in the online edition of Science Translational Medicine.
The mouse model could also have clinical applications, such as predicting how a particular patient might ...
Study finds expensive procedure no more effective than medical therapy to prevent strokes
2012-03-15
CLEVELAND -- A catheter procedure that closes a hole in patients' hearts was no more effective than medical therapy in preventing recurrent strokes, according to a new study published in the March 15 issue of the New England Journal of Medicine.
In the CLOSURE I trial, clinical researchers compared a catheter procedure plus medical therapy with medications alone to prevent new strokes or transient ischemic attacks (TIAs) in patients between 18 and 60 years old with an unexplained ("cryptogenic") stroke or TIA and a patent foremen ovale (PFO) – a hole between the heart's ...
Researchers identify unexpected player in intestinal immunity
2012-03-15
VIDEO:
Using two-photon imaging, the researchers were able to see dendritic cells, shown in green, in the intestine of a living mouse.
Click here for more information.
With every meal, immune cells in the intestine stand like sentries at a citadel, turning away harmful bacteria but allowing vitamins and nutrients to pass.
Now, researchers at Washington University School of Medicine in St. Louis have identified the cells that chaperone food antigens, or proteins, in the ...
Mortgage Settlement Allotment to Struggling WI Homeowners: Too Little too Late?
2012-03-15
Of the $25 billion federal settlement funds for mortgage foreclosure abuses, Wisconsin will receive $140 million. The settlement money is being paid by J.P. Morgan Chase, Bank of America, Wells Fargo & Co, Citigroup and Ally (formerly GMAC), and is intended to help homeowners having difficulty making their mortgage payments and individuals who were the victims of improper foreclosures.
According to Assistant Attorney General Holly Pomraning in a recent TheNorthwestern.com article, Wisconsin's share of the settlement will be divided and distributed as follows:
- ...
CDC study shows outbreaks linked to imported foods increasing
2012-03-15
Foodborne disease outbreaks caused by imported food appeared to rise in 2009 and 2010, and nearly half of the outbreaks implicated foods imported from areas which previously had not been associated with outbreaks, according to research from the Centers for Disease Control and Prevention, presented today at the International Conference on Emerging Infectious Diseases in Atlanta.
"It's too early to say if the recent numbers represent a trend, but CDC officials are analyzing information from 2011 and will continue to monitor for these outbreaks in the future," said Hannah ...
Influenza 'histone mimic' suppresses antiviral response
2012-03-15
A team of researchers led by scientists at The Rockefeller University has identified a novel mechanism by which influenza interferes with antiviral host response. The finding, reported in this week's issue of the journal Nature, shows that the immunosuppressive NS1 protein of the influenza A virus hijacks key regulators of antiviral gene function by mimicking a core component of gene regulating machinery. The results they describe have major implications for our understanding of the biology of seasonal influenza virus and its pathogenesis. This research also suggests a ...
Nano spiral staircases modify light
2012-03-15
There was a lot of excitement a few years ago following the discovery of the DNA origami technique. The approach could be used to build nanoparticles of a given shape and size. However, real applications, such as nano-tweezers, remained out of reach. An international team of researchers led by Professor Tim Liedl of the Ludwig-Maximillians-Universitaet Muenchen and Professor Friedrich Simmel of the Technische Universitaet Muenchen have now succeeded in building nanoparticles using optically active DNA building blocks that can be used to modify light in very specific ways.
Coupling ...
LAST 30 PRESS RELEASES:
Post-LLM era: New horizons for AI with knowledge, collaboration, and co-evolution
“Sloshing” from celestial collisions solves mystery of how galactic clusters stay hot
Children poisoned by the synthetic opioid, fentanyl, has risen in the U.S. – eight years of national data shows
USC researchers observe mice may have a form of first aid
VUMC to develop AI technology for therapeutic antibody discovery
Unlocking the hidden proteome: The role of coding circular RNA in cancer
Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC
Study reveals widening heart disease disparities in the US
The role of ubiquitination in cancer stem cell regulation
New insights into LSD1: a key regulator in disease pathogenesis
Vanderbilt lung transplant establishes new record
Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine
Metasurface technology offers a compact way to generate multiphoton entanglement
Effort seeks to increase cancer-gene testing in primary care
Acoustofluidics-based method facilitates intracellular nanoparticle delivery
Sulfur bacteria team up to break down organic substances in the seabed
Stretching spider silk makes it stronger
Earth's orbital rhythms link timing of giant eruptions and climate change
Ammonia build-up kills liver cells but can be prevented using existing drug
New technical guidelines pave the way for widespread adoption of methane-reducing feed additives in dairy and livestock
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
New study finds that tooth size in Otaria byronia reflects historical shifts in population abundance
nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip
Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure
Fluoride in drinking water is associated with impaired childhood cognition
New composite structure boosts polypropylene’s low-temperature toughness
While most Americans strongly support civics education in schools, partisan divide on DEI policies and free speech on college campuses remains
Revolutionizing surface science: Visualization of local dielectric properties of surfaces
LearningEMS: A new framework for electric vehicle energy management
Nearly half of popular tropical plant group related to birds-of-paradise and bananas are threatened with extinction
[Press-News.org] Study Shows Chemotherapy Combination Effective for Mesothelioma PatientsA particular combination of chemotherapy drugs is proving effective at treating Mesothelioma.